RNTX earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -0.44. Updated 2026-07-23.
Rein Therapeutics (RNTX) Research Hub
Rein Therapeutics (RNTX) trades on NASDAQ, US in the Healthcare (Medical - Pharmaceuticals) sector. As of 2026-09-11, shares last closed at 0.785 USD (-5.14%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.44, market cap 0.02B. This hub links to the full technical, earnings and options research available for RNTX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Pharmaceuticals) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.785 USD (-5.14%) |
| 52-week range | 0.72 USD – 1.05 USD |
| Trend regime | Range |
| 14-day RSI | 46.5 (Neutral) |
| Trailing P/E | -0.44 |
| Market cap | 0.02B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for RNTX
Covered Call on RNTX: how it works, illustrative setup around the real 0.785 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on RNTX: how it works, illustrative setup around the real 0.785 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on RNTX: how it works, illustrative setup around the real 0.785 USD price, max profit/loss, breakeven and when to use it. Educational.
RNTX technical analysis: range, last 0.785 USD, RSI 46.5, 52w range 0.72 USD–1.05 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is RNTX in?
Rein Therapeutics (RNTX) is classified under Healthcare (Medical - Pharmaceuticals), listed on NASDAQ, US.
Is RNTX in an uptrend or downtrend?
As of 2026-09-11, RNTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is RNTX's trailing P/E ratio?
RNTX's trailing P/E is -0.44, with a market cap of 0.02B. See the earnings research page for full valuation detail.
When does RNTX next report earnings?
RNTX is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.17 USD.